Reports suggest AstraZeneca has engaged in discussions with its US counterpart, Bristol Myers Squibb, regarding a potential merger that could establish a pharmaceutical behemoth valued at over £300 billion.
Henry Saker-Clark is a journalist at PA, where he serves as the deputy business editor with a particular focus on retail, hospitality, and leisure. His reporting delves into areas such as corporate finance, consumer behavior analytics, and the broader economy, highlighting trends in both brick-and-mortar and e-commerce sectors. Henry's work has been featured in numerous outlets, including Edinburgh Live, Yahoo Sports UK, and The Scotsman.
